MiR-451 as a new tumor marker for gastric cancer
نویسندگان
چکیده
منابع مشابه
MiR-451 as a new tumor marker for gastric cancer
Gastric cancer is the second most common malignancy in China. However, the prognosis for gastric cancer patients remains poor. The purpose of this study was to investigate whether miR-451 was a potential prognostic biomarker for gastric cancer. Fresh tissues were immediately frozen in liquid nitrogen until use. The plasma was extracted and quantitative real-time polymerase chain reaction was pe...
متن کاملEvaluating the Expression of Oct4 as a Prognostic Tumor Marker in Bladder Cancer
Objective(s)The key transcriptional regulator Oct4 is one of the self-renewal and differentiation-related factors in cancer stem cells, where it maintains "stemness" state. Cancer stem cells have been identified in a variety of solid malignancies. They are a small population of tumor cells with stem cell characteristics, which are a likely cause of relapse in cancer patients. Due to high incide...
متن کاملSerum Galectin-3 as a Potential Marker for Gastric Cancer
BACKGROUND The identification of cancer biomarkers can advance the possibility for early detection and better monitoring of tumor progression. The aim of this study was to assess the diagnostic and prognostic value of serum galectin-3(Gal-3) in patients with gastric cancer (GC). MATERIAL AND METHODS We measured serum Gal-3 levels using ELISA method in 87 patients with GC, 53 patients with ben...
متن کاملevaluating the expression of survivin gene as a specific tumor marker for prognosis of bladder cancer
objective: inhibition of apoptosis may favor the onset and progression of cancer. survivin is an inhibitor of apoptosis that has been considered as a potential marker for diagnostic and/or prognostic of bladder cancer. the survivin protein regulates both cell division and cell death and is overexpressed in the vast majority of human cancers. in this study, the expression pattern and potential p...
متن کاملSerum miR-1290 as a marker of pancreatic cancer--letter.
Authors’ Affiliations: HPB Surgical Unit and Division of Oncology, both in Department of Surgery & Cancer, Imperial College, Hammersmith Hospital campus, Du Cane Road, London, W12 0HS, United Kingdom; and Departments of Surgery and Medical Oncology, VU University Medical Center, Amsterdam, the Netherlands. Corresponding Author: Elisa Giovannetti, Department of Medical Oncology, VU University Me...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Oncotarget
سال: 2017
ISSN: 1949-2553
DOI: 10.18632/oncotarget.17239